title: Rebuttal: the CTO "no-controversy" controversy: should the field of CTO-PCI be allowed to expand?
authors.forename: E Marc
authors.initials: EM
authors.lastname: Jolicoeur
authors.forename: Micheal J
authors.initials: MJ
authors.lastname: Sketch
authors.forename: Manesh R
authors.initials: MR
authors.lastname: Patel
authors.forename: James E
authors.initials: JE
authors.lastname: Tcheng
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000209:etiology*; D054059:Coronary Occlusion / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male